Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 10, 2008, Pages 1384-1388

  Koseki, Takuma ^a   Onishi, Hiraku ^a   Takahashi, Yuri ^a   Uchida, Minoru ^b   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Disintegration time; Fast disintegrating tablet; Furosemide; Hardness; Sucrose stearic acid ester

Indexed keywords

ALCOHOL; CROSCARMELLOSE SODIUM; DISINTEGRATING AGENT; DRUG ADDITIVE; ESTER DERIVATIVE; FUROSEMIDE; MICROCRYSTALLINE CELLULOSE; ORGANIC SOLVENT; SUCROSE STEARIC ACID ESTER; UNCLASSIFIED DRUG; XYLITOL;

ADDITION REACTION; ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; FAST DISINTEGRATING TABLET; FREEZE DRYING; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET HARDNESS; TECHNIQUE; WETTABILITY;

ANTIHYPERTENSIVE AGENTS; CARBOXYMETHYLCELLULOSE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DIURETICS; DRUG COMPOUNDING; ESTERS; ETHANOL; EXCIPIENTS; FLAVORING AGENTS; FUROSEMIDE; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SOLVENTS; STEARIC ACIDS; SUCROSE; TABLETS; XYLITOL;

EID: 54349089594     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1384     Document Type: Article

References (26)

1. González-Rodríguez M. L., Maestrelli F., Mura P., Rabasco A. M., Eur. J. Pharm. Sci., 20, 125-131 (2003).
2. Tapia C., Ormazabal V., Costa E., Yazdani-Pedram M., Drug Dev. Ind. Pharm., 33, 585-593 (2007).
3. Pearnchob N., Siepmann J., Bodmeier R., Drug Dev. Ind. Pharm., 29, 925-938 (2003).
4. Ohmori S., Ohno Y., Makino T., Kashihara T., Eur. J. Pharm. Biopharm., 59, 289-297 (2005).
5. Seager H., J. Pharm. Pharmacol., 50, 375-382 (1998).
6. Baldi F., Malfertheiner P., Digestion, 67, 1-5 (2003).
7. de Argila C. M., Ponce J., Márquez E., Plazas M. J., Galván J., Heras J., Porcel J., Clin. Drug Investig., 27, 765-770 (2007).
8. Corveleyn S., Remon J. P., Drug Dev. Ind. Pharm., 25, 1005-1013 (1999).
9. Fu Y., Yang S., Jeong S. H., Kimura S., Park K., Crit. Rev. Ther. Drug Carrier Syst., 21, 433-476 (2004).
10. Ahmed I. S., Aboul-Einien M. H., Eur. J. Pharm. Sci., 32, 58-68 (2007).
11. Fukami J., Yonemochi E., Yoshihashi Y., Terada K., Int. J. Pharm., 310, 101-109 (2006).
12. Mutasem M., Rawas-Qalaji M. M., Simons F. E., Simons K. J., AAPS PharmSciTech, 7, E1-E7 (2006).
13. Jin Y., Ohkuma H., Wang H., Natsume H., Sugibayashi K., Morimoto Y., Yakugaku Zasshi, 122, 989-994 (2002).
14. Fukami J., Ozawa A., Yoshihashi Y., Yonemochi E., Terada K., Chem. Pharm. Bull., 53, 1536-1539 (2005).
15. Waller E. S., Crismon M. L., Smith R. V., Bauza M. T., Doluisio J. T., Biopharm. Drug Dispos., 9, 211-218 (1988).
16. Yagi N., Kiuchi T., Satoh H., Terashima Y., Kenmotsu H., Sekikawa H., Takada M., Biol. Pharm. Bull., 19, 616-622 (1996).
17. Aoshima H., Miyagisnima A., Nozawa Y., Sadzuka Y., Sonobe T., Int. J. Pharm., 293, 25-34 (2005).
18. Publication of Japanese Patent Application No. 2002-3405 (2002).
19. Terashi M., Journal of Kagoshima City Medical Assocoation, 43, 20 (2004).
20. Publication of Japanese Patent Application No. 1999-12162 (1999).
21. Publication of Japanese Patent Application No. 2001-139461 (2001).
22. Publication of Japanese Patent Application No. 2001-163770 (2001).
23. Publication of Japanese Patent Application No. 2007-332074 (2007).
24. Tang H., Xu N., Meng J., Wang C., Nie S. F., Pan W. S., Yakugaku Zasshi, 127, 1851-1862 (2007).
25. Okamoto H., Sakai T., Danjo K., Biol. Pharm. Bull., 28, 1689-1694 (2005).
26. Csóka G., Marton S., Zelko R., Otomo N., Antal I., Eur. J. Pharm. Biopharm., 65, 233-237 (2007).